Bile Duct Mixed Neuroendocrine-nonendocrine Neoplasm with a Complete Response to Chemoradiotherapy

Intern Med. 2024 May 1;63(9):1243-1246. doi: 10.2169/internalmedicine.2555-23. Epub 2023 Sep 29.

Abstract

The incidence of neuroendocrine carcinomas arising from the bile duct is low, and that of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) is even lower; therefore, there is no standard treatment for MiNENs. Choosing the appropriate treatment in clinical practice is difficult. We herein report a case of unresectable extrahepatic bile duct MiNEN in a 66-year-old man who received curative chemoradiotherapy and achieved a complete response, remaining recurrence-free for 2.5 years. We consider the findings of this case to be valuable in selecting a treatment strategy for unresectable bile duct MiNENs.

Keywords: bile duct cancer; chemoradiotherapy; mixed neuroendocrine-nonendocrine neoplasm (MiNEN); neuroendocrine cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bile Duct Neoplasms* / diagnostic imaging
  • Bile Duct Neoplasms* / drug therapy
  • Bile Duct Neoplasms* / therapy
  • Carcinoma, Neuroendocrine / diagnostic imaging
  • Carcinoma, Neuroendocrine / drug therapy
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / therapy
  • Chemoradiotherapy* / methods
  • Humans
  • Male
  • Neuroendocrine Tumors / diagnostic imaging
  • Neuroendocrine Tumors / therapy
  • Treatment Outcome